# Research Pulse — 2026-06-09 _Generated 2026-06-09 00:16 KST_ Daily Brown Biotech research pulse. PubMed/PMC scan across 28 journals × 7 topics, grouped into query families aligned with active Brown Biotech pipelines. ### 1. OXPHOS & Mitochondrial Vulnerability (0 hits) _Brown Biotech relevance: KEAP1/NRF2, MASH lipotoxicity, ARP v27 target #18_ - (no fresh hits today) ### 2. MASH Liver Atlas & DGAT2 (0 hits) _Brown Biotech relevance: DGAT1/2 TPP, Sargassum japonica pipeline_ - (no fresh hits today) ### 3. Ferroptosis & Lipid Peroxidation (0 hits) _Brown Biotech relevance: GPX4, ACSL4, lipid droplet biology, KEAP1 mechanism_ - (no fresh hits today) ### 4. Sarcopenia Single-Cell (0 hits) _Brown Biotech relevance: D+Q + pioglitazone senolytic, HBAT brown adipose_ - (no fresh hits today) ### 5. Aging Muscle Atlas (0 hits) _Brown Biotech relevance: longevity-db cc-by-4.0, cross-tissue aging clock_ - (no fresh hits today) ### 6. Frailty Multi-Omics (3 hits) _Brown Biotech relevance: longevity platform, anti-aging cosmetics research_ - [FDA recall: Atomoxetine Capsules HCL, 10 mg Capsules in unit dose foil strip, strips are packed in cartons of 100, Rx Only, Pkg by:](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts#D-0538-2026) — FDA - [FDA recall: fentaNYL Citrate, Sterile CADD for Injection, 2,2500 mcg/50mL in Sterile Water, IntegraDose Compounding Services LLC, 36](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts#D-0548-2026) — FDA - [FDA recall: Erythromycin Tablets, USP, 500 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad,](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts#D-0545-2026) — FDA ### 7. Muscle Fibrosis Spatial Transcriptomics (0 hits) _Brown Biotech relevance: anti-fibrotic pipeline, FAP subsets_ - (no fresh hits today) ### 8. Skeletal Muscle Aging Visium (0 hits) _Brown Biotech relevance: spatial workflow validation, type II fiber atrophy_ - (no fresh hits today) ### 9. Human Aging Cohort Metabolomics (3 hits) _Brown Biotech relevance: longevity diagnostics, biomarker discovery_ - [ADC biotech Ona Therapeutics secures $86.6M in Series B raise](https://endpoints.news/adc-biotech-ona-therapeutics-secures-86-6m-in-series-b-raise/) — Endpoints News - [Isomorphic Labs announces Series B investment round](https://www.isomorphiclabs.com/articles/isomorphic-labs-announces-series-b-investment-round) — Isomorphic Labs - [Careers Inside Isomorphic Labs' Lausanne office 18.02.25](https://www.isomorphiclabs.com/articles/inside-isomorphic-labs-lausanne-office) — Isomorphic Labs ### 10. Fibroblast Atlas (1 hit) _Brown Biotech relevance: CTHRC1+ fibrogenic subset, CMap repurposing_ - [GSK pledges £44M to UK biotech to explore fibrosis regression](https://www.fiercebiotech.com/biotech/gsk-pledges-ps445m-near-term-uk-biotech-tackle-liver-fibrosis-regression) — Fierce Biotech ### 11. FAP Spatial Transcriptomics (0 hits) _Brown Biotech relevance: cross-tissue FAP atlas, IPF lung_ - (no fresh hits today) ### 12. MASH Liver Atlas (snRNA-seq) (0 hits) _Brown Biotech relevance: hepatic stellate cell activation trajectories_ - (no fresh hits today) ### 13. Lung Fibrosis Spatial Atlas (0 hits) _Brown Biotech relevance: IPF CTHRC1+ signaling hub, bleomycin model_ - (no fresh hits today) ### 14. Senescence & Senolytic (0 hits) _Brown Biotech relevance: D+Q + pioglitazone, HBAT activation, senotype deep learning_ - (no fresh hits today) ### 15. Immunology & Tumor Microenvironment (0 hits) _Brown Biotech relevance: NK cell, macrophage polarization, immune checkpoint, T cell exhaustion, Science Immunology_ - (no fresh hits today) ### Other live signals (5 hits) - [GSK inks multi-target liver pact with Engitix; Sangamo considers strategic options](https://endpoints.news/gsk-inks-multi-target-pact-with-engitix-sangamo-considers-strategic-options/) — Endpoints News - [J&J makes $1B move for Firefly Bio, Carolyn Bertozzi's twist on ADCs in KRAS field](https://endpoints.news/jj-makes-1b-move-for-firefly-bio-carolyn-bertozzis-twist-on-adcs-in-kras-field/) — Endpoints News - [Incyte inks $2B deal to add Star biz to late-phase constellation](https://www.fiercebiotech.com/biotech/incyte-inks-2b-deal-add-star-unit-late-phase-constellation-and-challenge-takeda) — Fierce Biotech - [Incyte to buy bleeding disorder biotech Vega Therapeutics in $1.25B upfront deal](https://endpoints.news/incyte-to-buy-bleeding-disorder-biotech-vega-therapeutics-in-1-25b-upfront-deal/) — Endpoints News - [Cavalry Biosciences pursues $75M Series B to test eye and muscle disorder drugs](https://endpoints.news/cavalry-biosciences-pursues-75m-series-b-to-test-eye-and-muscle-disorder-drugs/) — Endpoints News --- **Totals:** 7 query-family hits across 15 families. _Source: Brown Biotech daily signal feed (`brown_biotech_daily_signal_feed.py`). For deep-dive synthesis, see `/Users/ocm/openclaw/workspace/arp-v27/literature/`._
Research Pulse·2026-06-09
Research Pulse — 2026-06-09
28 journals × 7 topics · fibrosis · OXPHOS · ferroptosis · sarcopenia · senescence
Raw data + scoring: Daily Tech Digest (separate feed)
Request a Paid Brief